Lundbeck
HLUN-B.CO
#2596
Rank
โ‚ฌ5.69 B
Marketcap
6,00ย โ‚ฌ
Share price
0.63%
Change (1 day)
4.20%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2025 (TTM): โ‚ฌ0.75 Billion

According to Lundbeck's latest financial reports the company's current earnings are โ‚ฌ3.61 Billion. In 2024 the company made an earning of โ‚ฌ0.47 Billion, an increase over its 2023 earnings that were of โ‚ฌ0.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ0.75 B58.91%
2024 โ‚ฌ0.47 B25.74%
2023 โ‚ฌ0.37 B21.77%
2022 โ‚ฌ0.31 B31.57%
2021 โ‚ฌ0.23 B-4.61%
2020 โ‚ฌ0.24 B-45.06%
2019 โ‚ฌ0.45 B-34.04%
2018 โ‚ฌ0.68 B12.83%
2017 โ‚ฌ0.60 B93.99%
2016 โ‚ฌ0.31 B-137.28%
2015 -โ‚ฌ0.84 Billion-1246.24%
2014 โ‚ฌ73.02 M-72.36%
2013 โ‚ฌ0.26 B4.38%
2012 โ‚ฌ0.25 B-55.18%
2011 โ‚ฌ0.56 B5.65%
2010 โ‚ฌ0.53 B-5.9%
2009 โ‚ฌ0.56 B